15 completed, 5 unknown, 2 terminated, 1 recruiting. 7 Phase 4, 4 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Not applicable | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 2 | Completed 2 |
Follow Clopidogrel 75mg: new trials by email Literature Review of Clopidogrel 75mg trials Research Report on Clopidogrel 75mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-dose NOAC Versus GDMT After LAAO Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg - Atrial Fibrillation | Not applicable | Recruiting | Xijing Hospital | 4220 | 2023-07-06 | 2023-07-27 |
| Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale Aspirin 300mg, Metoprolol 25mg, Clopidogrel 75mg - Patent Foramen Ovale, Migraine | Phase 2 | Completed | Chinese Academy of Medical Sciences, Fuwai Hospital | 1000 | 2022-10-15 | 2026-04-22 |
| Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling Aspirin 100mg, Clopidogrel 75mg - Aneurysm Cerebral, Endovascular Procedures | Phase 4 | Completed | Seoul National University Bundang Hospital | 528 | 2022-06-23 | 2025-12-19 |
| Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA Cilostazol 100 MG, Clopidogrel 75mg - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 870 | 2022-04-15 | 2024-09-19 |
| Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia Rivaroxaban 15 MG, Acetylsalicylic acid 100mg, Clopidogrel 75 Mg Oral Tablet - Acute Coronary Syndrome, Coronary Artery Ectasia | Phase 2 | Unknown | Instituto Nacional de Cardiologia Ignacio Chavez | 60 | 2021-09-01 | 2022-02-10 |
| Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. Aspirin 75mg, Clopidogrel 75mg, Rivaroxaban 2.5 MG - COVID-19 | Not applicable | Terminated | Imperial College London | 320 | 2020-04-03 | 2023-01-18 |
| Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. Apixaban, ASA, Clopidogrel 75mg - Critical Limb Ischemia | Phase 3 | Unknown | Science Valley Research Institute | 200 | 2020-01-09 | 2021-04-20 |
| Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers Clopidogrel 75mg, Tegoprazan 50 mg, RAPA113 - Healthy | Phase 1 | Completed | HK inno.N Corporation | 36 | 2019-10-21 | 2020-05-08 |
| Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data Prasugrel 10mg, Clopidogrel 75mg - Antiplatelet | Completed | Brigham and Women's Hospital | 43864 | 2019-09-22 | 2023-07-27 | |
| Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data Ticagrelor 90mg, Clopidogrel 75mg - Antiplatelet | Completed | Brigham and Women's Hospital | 27960 | 2019-09-22 | 2023-07-27 | |
| LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention Ticagrelor 90mg, Ticagrelor 90mg/60mg, Clopidogrel 75mg - Antiplatelet Therapy, Coronary Artery Disease | Phase 4 | Unknown | Beijing Anzhen Hospital | 225 | 2019-08-30 | 2019-08-19 |
| Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease Ticagrelor 90mg, Clopidogrel 75mg - Platelet Reactivity | Phase 4 | Completed | First Affiliated Hospital of Harbin Medical University | 50 | 2019-07-02 | 2022-01-11 |
| Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19 Vicagrel 6mg, Clopidogrel 75mg - Healthy Subjects, PK/PD | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 50 | 2019-04-03 | 2019-09-19 |
| The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease（AURORA） Aspirin 100 mg, Clopidogrel 75mg - Coronary Artery Disease, Hyperuricemia | Unknown | Shanghai Zhongshan Hospital | 2000 | 2018-12-01 | 2018-11-29 | |
| Chronic Kidney Disease (CKD) Platelet Study Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg - Chronic Kidney Diseases, Heart Attack | Phase 3 | Completed | University of Arkansas | 76 | 2018-11-01 | 2022-12-29 |
| Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke Aspirin, Clopidogrel 75mg, Alteplase - Stroke | Phase 4 | Completed | General Hospital of Shenyang Military Region | 760 | 2018-10-17 | 2022-08-03 |
| Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes Ticagrelor 90mg, Clopidogrel 75mg, acetylsalicylic acid (ASA) 81mg - Acute Coronary Syndrome | Phase 4 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 1038 | 2018-10-01 | 2023-11-03 |
| The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel Vicagrel 5mg, Vicagrel 6mg, Vicagrel 7.5mg - Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 2 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 279 | 2018-08-30 | 2019-09-23 |
| A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) Ticagrelor 60mg, Clopidogrel 75mg, Aspirin 81 mg - Stable Coronary Syndrome, Percutaneous Coronary Intervention | Phase 4 | Terminated | Ottawa Heart Institute Research Corporation | 5 | 2017-08-18 | 2019-07-19 |
| Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel Ticagrelor 180mg, Clopidogrel 75mg - Blood Loss, Surgical, Ticagrelor | Completed | Ajou University School of Medicine | 1097 | 2016-01-01 | 2020-06-16 |
Showing 20 of 23. Sign in to see all of them.
Coronary Artery Disease (5) · Acute Coronary Syndrome (2) · Ischemic Stroke (2) · Myocardial Infarction (2) · Stroke (2) · Angina, Stable (1) · Atrial Fibrillation (1) · Blood Loss, Surgical (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Chronic Limb-Threatening Ischemia (1) · Coronary Aneurysm (1) · Coronary Disease (1) · Coronavirus Infections (1) · Foramen Ovale, Patent (1)
Brigham and Women's Hospital (2) · Chinese Academy of Medical Sciences, Fuwai Hospital (2) · Jiangsu vcare pharmaceutical technology co., LTD (2) · Ajou University School of Medicine (1) · Beijing Anzhen Hospital (1) · First Affiliated Hospital of Harbin Medical University (1) · General Hospital of Shenyang Military Region (1) · HK inno.N Corporation (1) · Imperial College London (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · Kafrelsheikh University (1) · Korea University Anam Hospital (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Ottawa Heart Institute Research Corporation (1) · Science Valley Research Institute (1)
China (9) · South Korea (4) · United States (3) · Canada (2) · Brazil (1) · Egypt (1) · Mexico (1) · United Kingdom (1)
Shirley Wang, PhD, ScM (2) · Alexandra Arias Mendoza, MD (1) · Chao Gao, M.D., Ph.D. (1) · Derek So, MD (1) · Diego Araiza Garaygordobil, MD, MSc (1) · Huisheng Chen, Doctor (1) · Jain Nishank, MD (1) · James Brophy, MD, PhD (1) · Junbo Ge, MD (1) · Ling Tao, M.D., Ph.D. (1) · Min Soo Park (1) · O-Ki Kwon (1) · Prapa Kanagaratnam, FRCP, PhD (1) · Seung-Jung Park, MD, PhD (1) · Xiangbin Pan (1)
PMID 33327727, PMID 18190818, PMID 29420189, PMID 31867054, PMID 32730905, PMID 35224730, PMID 35904750, PMID 36682595, PMID 37367978, PMID 38109984, PMID 39014552, PMID 39387110, PMID 39615618, PMID 39663175, PMID 40164463, PMID 40371069, PMID 40760234, PMID 41128284, PMID 42526943